Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 355 Neoplasms 252 Carcinoma, Non-Small-Cell Lung 199 Colorectal Neoplasms 181 Lung Neoplasms 151 Prostatic Neoplasms 150 Carcinoma, Hepatocellular 127 Leukemia, Myeloid, Acute 96 Pancreatic Neoplasms 86 Multiple Myeloma 82 Neoplasm Metastasis 73 Recurrence 72 Uterine Cervical Neoplasms 68 Rectal Neoplasms 68 Ovarian Neoplasms 65 Stomach Neoplasms 64 Triple Negative Breast Neoplasms 59 Squamous Cell Carcinoma of Head and Neck 57 Brain Neoplasms 56 Head and Neck Neoplasms 55 Glioblastoma 55 Precursor Cell Lymphoblastic Leukemia-Lymphoma 51 Small Cell Lung Carcinoma 48 Melanoma 45 Endometrial Neoplasms 43 Disease 43 Esophageal Neoplasms 42 Hematologic Neoplasms 41 Glioma 41 Colonic Neoplasms 41

Interventions

selpercatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Cachexia-Anorexia Syndrome × 1 year × Clear all

NCT07146893 2026-01-15

FEATHER

University of Oklahoma

Phase EARLY_PHASE1 Not yet recruiting

Cachexia-Anorexia Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡